yttrium radioisotopes has been researched along with Malignant Carcinoid Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bencze, A; Igaz, P; Leiszter, K; Nagy, Z; Patócs, A; Rácz, K; Szücs, N | 1 |
| Bartolomei, M; Bodei, L; Davì, MV; Falconi, M; Ferdeghini, M; Francia, G; Lo Cascio, V; Oliani, C; Paganelli, G; Reghellin, D; Scilanga, L | 1 |
2 other study(ies) available for yttrium radioisotopes and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
[Carcinoid heart disease].
Topics: Carcinoid Heart Disease; Diagnosis, Differential; Echocardiography, Doppler, Color; Flushing; Humans; Ileal Neoplasms; Lymphatic Metastasis; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Prognosis; Radiotherapy, Adjuvant; Severity of Illness Index; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid).
Topics: Aged; Bone Neoplasms; Bronchial Neoplasms; Carcinoid Tumor; Humans; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Octreotide; Yttrium Radioisotopes | 2006 |